Pfizer’s Departing C.E.O. Will Be Known for the Deals He Didn’t Complete
Ian Read leaves the pharmaceutical company, with eight years of deal-making tarnished by two failed takeovers aimed at m...
Ian Read leaves the pharmaceutical company, with eight years of deal-making tarnished by two failed takeovers aimed at m...